These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 11284621)

  • 1. Docetaxel (Taxotere) in combination with radiation therapy and the potential of weekly administration in elderly and/or poor performance status patients with advanced non-small cell lung cancer.
    Hainsworth JD; Vokes EE
    Semin Oncol; 2001 Feb; 28(1 Suppl 2):22-7. PubMed ID: 11284621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docetaxel (Taxotere) in combination with radiation therapy and the potential of weekly administration in elderly and/or poor performance status patients with advanced non-small cell lung cancer.
    Hainsworth JD; Vokes EE
    Semin Oncol; 2001 Feb; 28 Suppl 2():22-27. PubMed ID: 28140078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I study of docetaxel with concomitant thoracic radiation therapy.
    Mauer AM; Masters GA; Haraf DJ; Hoffman PC; Watson SM; Golomb HM; Vokes EE
    J Clin Oncol; 1998 Jan; 16(1):159-64. PubMed ID: 9440738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docetaxel in the treatment of non-small cell lung cancer: review of single-agent trials.
    Fossella FV
    Semin Oncol; 1999 Oct; 26(5 Suppl 16):17-23; discussion 41-2. PubMed ID: 10585004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weekly docetaxel as a single agent and in combination with gemcitabine in elderly and poor performance status patients with advanced non--small cell lung cancer.
    Hainsworth JD; Burris HA; Greco FA
    Semin Oncol; 2001 Jun; 28(3 Suppl 9):21-5. PubMed ID: 11441411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined-modality therapy for advanced non-small cell lung cancer: paclitaxel and thoracic irradiation.
    Choy H; Yee L; Cole BF
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):38-44. PubMed ID: 8643969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docetaxel and radiation as combined-modality therapy.
    Kim ES; Khuri FR
    Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):97-105. PubMed ID: 12108904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel (Taxotere) as a single agent and in combination chemotherapy for the treatment of patients with advanced non-small cell lung cancer.
    Miller VA; Kris MG
    Semin Oncol; 2000 Apr; 27(2 Suppl 3):3-10. PubMed ID: 10810932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent twice-a-week docetaxel and radiotherapy: a dose escalation trial with immunological toxicity evaluation.
    Koukourakis MI; Giatromanolaki A; Schiza S; Kakolyris S; Georgoulias V
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):107-14. PubMed ID: 9989521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weekly paclitaxel and cisplatin with concurrent radiotherapy in locally advanced non-small-cell lung cancer: a phase I study.
    Frasci G; Comella P; Scoppa G; Guida C; Gravina A; Fiore F; Casaretti R; Daponte A; Parziale A; Comella G
    J Clin Oncol; 1997 Apr; 15(4):1409-17. PubMed ID: 9193333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docetaxel (Taxotere) and vinorelbine in the treatment of non-small cell lung cancer.
    Georgoulias V; Kourousis C; Androulakis N; Kakolyris S; Papadakis E; Bouros D; Apostolopoulou F; Georgopoulou T; Agelidou M; Souglakos J; Halkiadakis G; Hatzidaki D
    Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-9-S14-14. PubMed ID: 9335517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I study of weekly docetaxel and cisplatin concurrent with thoracic radiotherapy in Stage III non-small-cell lung cancer.
    Wu HG; Bang YJ; Choi EK; Ahn YC; Kim YW; Lim TH; Suh C; Park K; Park CI
    Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):75-80. PubMed ID: 11777624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docetaxel (Taxotere) administered in weekly schedules.
    Greco FA
    Semin Oncol; 1999 Jun; 26(3 Suppl 11):28-31. PubMed ID: 10458208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twice-weekly paclitaxel and radiation for stage III non-small cell lung cancer.
    Lau DH; Ryu JK; Gandara DR; Morgan R; Doroshow J; Wilder R; Leigh B
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-106-S12-109. PubMed ID: 9331132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose escalation of docetaxel concomitant with hypofractionated, once weekly chest radiotherapy for non-small-cell lung cancer: a phase I study.
    Schwarzenberger P; Theodossiou C; Barron S; Diethelm L; Boyle M; Harrison L; Wynn RB; Salazar OM; Fariss A
    Am J Clin Oncol; 2004 Aug; 27(4):395-9. PubMed ID: 15289734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docetaxel (Taxotere) shows survival and quality-of-life benefits in the second-line treatment of non-small cell lung cancer: a review of two phase III trials.
    Shepherd FA; Fossella FV; Lynch T; Armand JP; Rigas JR; Kris MG
    Semin Oncol; 2001 Feb; 28(1 Suppl 2):4-9. PubMed ID: 11284623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weekly docetaxel with concurrent radiotherapy in locally advanced non-small cell lung cancer: a phase I/II study with 5 years' follow-up.
    Brunsvig PF; Hatlevoll R; Berg R; Lauvvang G; Owre K; Wang M; Aamdal S
    Lung Cancer; 2005 Oct; 50(1):97-105. PubMed ID: 16005105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weekly administration of docetaxel (Taxotere): summary of clinical data.
    Hainsworth JD; Burris HA; Greco FA
    Semin Oncol; 1999 Jun; 26(3 Suppl 10):19-24. PubMed ID: 10437747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent two-dimensional radiotherapy and weekly docetaxel in the treatment of stage III non-small cell lung cancer: a good local response but no good survival due to radiation pneumonitis.
    Onishi H; Kuriyama K; Yamaguchi M; Komiyama T; Tanaka S; Araki T; Nishikawa K; Ishihara H
    Lung Cancer; 2003 Apr; 40(1):79-84. PubMed ID: 12660011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docetaxel (Taxotere) in the treatment of non-small cell lung cancer: an international update.
    Kris MG; Manegold C
    Semin Oncol; 2001 Feb; 28(1 Suppl 2):1-3. PubMed ID: 11284618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.